ORTHOPEDIATRICS CORP Operating Income

Quick Answer

ORTHOPEDIATRICS CORP reported Operating Income of -$39.24 million for fiscal year 2025.

ORTHOPEDIATRICS CORP Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 -$39.24M -12.1%
2024 -$35.01M -30.9%
2023 -$26.75M -5.3%
2022 -$25.40M -40.9%
2021 -$18.02M +32.6%
2020 -$26.75M -194.8%
2019 -$9.08M +5.0%
2018 -$9.55M -47.6%
2017 -$6.47M -5.6%
2016 -$6.13M +7.1%
2015 -$6.59M

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
September 30, 2025 -$9.43M -69.4% +11.5%
June 30, 2025 -$10.66M -88.1% +3.0%
March 31, 2025 -$10.98M -12.9% -97.3%
September 30, 2024 -$5.57M -23.5% +1.8%
June 30, 2024 -$5.67M -1.4% +41.7%
March 31, 2024 -$9.72M -13.2% -115.7%
September 30, 2023 -$4.51M +35.2% +19.3%
June 30, 2023 -$5.59M -49.2% +35.0%
  • ORTHOPEDIATRICS CORP showed a decrease of -12.1% in Operating Income compared to the prior fiscal year.
  • Over the 2015–2025 period, ORTHOPEDIATRICS CORP’s operating income has declined by 495.2% (from -$6.59 million to -$39.24 million).
  • The most recent figure is from ORTHOPEDIATRICS CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment